SCHEMBL5325399

SCHEMBL5325399

CCC(c1ccccc1)c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.42
HRH1 P35367 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 2/20 0.41
SLC6A3 Q01959 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
KCNH2 Q12809 1/20 0.39
RBP1 P09455 1/20 0.39
TSHR P16473 1/20 0.39
TP53 P04637 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9808852 0.82 SIGMAR1 (0.42) HTR2AHRH1HTTMAPTCYP3A4
Formaldehyde SCHEMBL28095681 0.80 CYP1A2 (0.38) LMNAHTTMAPTSLC6A3CYP3A4
SCHEMBL27530741 0.80 MAPT (0.41) HTR2ALMNAHTTTDP1MAPT
SCHEMBL3908791 0.80 TSHR (0.42) HTTMAPTSLC6A3TSHROPRM1
SCHEMBL604916 0.80 TAAR1 (0.58) HTR2AHRH1MAPTSLC6A3SLC6A2
SCHEMBL15922032 0.79 RAB9A (0.40) LMNATDP1MAPTCYP2D6TSHR
SCHEMBL27482821 0.77 POLB (0.45) LMNAHTTMAPTTP53
SCHEMBL29290745 0.76 POLB (0.47) MAPTTSHR
SCHEMBL29208938 0.75 TSHR (0.40) LMNAHTTMAPTSLC6A3CYP3A4
SCHEMBL28785571 0.75 LMNA (0.35) LMNAHTTMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117886839-A Organic semiconductor luminescent compound and application thereof 冠能光电材料(深圳)有限责任公司 2024-04-16 CN claimed
CN-117534639-A Amide compound, preparation method and agronomic application thereof 南开大学 2024-02-09 CN claimed
CN-116804023-A Organic semiconductor luminescent compound and application thereof 冠能光电材料(深圳)有限责任公司 2023-09-26 CN claimed
CN-115947747-A Triptycene boron-nitrogen compound and application thereof 冠能光电材料(深圳)有限责任公司 2023-04-11 CN claimed
WO-2021134885-A1 HIGH-CONTRAST NEGATIVE LIQUID CRYSTAL COMPOSITION CONTAINING PHENYLPROPYLTHIOPHENE AND APPLICATION THEREOF 北京八亿时空液晶科技股份有限公司 2021-07-08 WO claimed
WO-2007094006-A1 PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM 1 LEE PHARMA LIMITED (IN) 2007-08-23 WO claimed
US-20070191609-A1 PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 LEE PHARMA LIMITED (IN) 2007-08-16 US claimed
US-20240229262-A1 Gold-Doped Nickel Nanocluster, Preparation Method Therefor, and Use Thereof INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) 2024-07-11 US disclosed
CN-118290264-A Method for synthesizing gamma-hydroxyaldehyde equivalent compound and application thereof 西湖大学 2024-07-05 CN disclosed
CN-117886839-A Organic semiconductor luminescent compound and application thereof 冠能光电材料(深圳)有限责任公司 2024-04-16 CN disclosed
CN-117534639-A Amide compound, preparation method and agronomic application thereof 南开大学 2024-02-09 CN disclosed
CN-117466745-A Method for synthesizing arylamine compound by using photochemical manganese as catalyst 陕西师范大学 2024-01-30 CN disclosed
CN-117466744-A Method for synthesizing arylamine compound by photochemical iron catalysis 陕西师范大学 2024-01-30 CN disclosed
CN-107910563-B Application of three-dimensional flaky nitrogen-sulfur co-doped porous carbon material 温州大学 2020-05-19 CN disclosed
CN-110760337-A Method and equipment for desulfurizing aromatic hydrocarbon raw material 中国石油化工股份有限公司 2020-02-07 CN disclosed
CN-101890002-A Application of phenylpropylthiophene derivative in preparation of anti-HIV medicament UNIV FUDAN 2010-11-24 CN disclosed
CN-101890002-A Application of phenylpropylthiophene derivative in preparation of anti-HIV medicament UNIV FUDAN 2010-11-24 CN disclosed
WO-2007094006-A1 PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE FORM 1 LEE PHARMA LIMITED (IN) 2007-08-23 WO disclosed
US-20070191609-A1 PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 LEE PHARMA LIMITED (IN) 2007-08-16 US disclosed
CN-1374963-A Remedies or preventives for freqent urination or arinary incontinence TORAY INDUSTRIES (JP) 2002-10-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191609-A1 PROCESS FOR PREPARATION OF CLOPIDOGREL BISULPHATE FORM-1 SULT1A1, SF1, ADH1C HTR2A 3136/4885HRH1 1583/4885LMNA 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.